This inventor holds 1 USPTO granted patent. Top assignee: Novozymes A/s. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovator Børge Diderichsen: Pioneering Hybrid Polypeptide Technologies
Introduction: Børge Diderichsen is a notable inventor based in København, Denmark. He is recognized for his significant contributions to biotechnology, particularly in the development of hybrid polypeptides. With one patent to his name, Diderichsen has made strides in his field while working for Novozymes A/S, a leader in enzyme production.
Latest Patents: Diderichsen's patent focuses on a method of providing a hybrid polypeptide exhibiting an activity of interest. This innovative method involves several processes:
1. Performing PCR amplification using an uncharacterized DNA sample and oligonucleotide primers associated with known genes encoding a polypeptide of interest to obtain PCR products.
2. Linking the PCR products to a 5' structural gene sequence and a 3' structural gene sequence, derived from genes that encode polypeptides reflecting the desired activity.
3. Expressing the resulting hybrid DNA sequences.
4. Screening the hybrid polypeptides to identify sequences encoding a polypeptide with the desired activity or a related function.
Career Highlights: Børge Diderichsen has cultivated a successful career in biotech, focusing on the development and enhancement of polypeptides. His innovative approach to hybrid polypeptide science has not only earned him a patent but has also contributed to advancements in enzyme technology and biopharmaceuticals.
Collaborations: Throughout his career, Diderichsen has collaborated with esteemed colleagues, including Henrik Dalbøge and Thomas Sandal. These partnerships reflect the collaborative spirit essential for pushing the boundaries of scientific research and innovation in biotechnology.
Conclusion: Børge Diderichsen is a valuable figure in the field of biotechnology, leveraging his expertise to innovate hybrid polypeptide technologies. As an inventor with a specific focus on methods that enhance polypeptide activities, his work at Novozymes A/S stands as a testament to the impact of collaboration and innovation in science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile